ATTO insider buying
Every open-market purchase of Attovia Therapeutics, Inc. (ATTO) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$52.37M
Insiders buying (12m)6
Purchases on record6
Last purchase filedAug 13, 2026
In the last 12 months, 6 insiders of Attovia Therapeutics, Inc. bought $52.37M of ATTO stock on the open market in 6 reported purchases. The most recent was filed on Aug 13, 2026: Walsh Colin (Director) bought 585,000 shares at $17.58, worth $10.29M.
Get the next ATTO insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll ATTO insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Aug 13 | Walsh ColinDirector | $10.29M | 585,000 | $17.58 | +24% | Aug 5 | SEC |
| Aug 13 | Goldman Sachs & Co. LLC +7Former 10% Owner | $10.29M | 585,000 | $17.58 | +24% | Aug 5 | SEC |
| Aug 10 | venBio Global Strategic Fund…10% Owner | $6.50M | 382,352 | $17.00 | +10% | Aug 6 | SEC |
| Aug 7 | Sanofi10% Owner | $5.10M | 300,000 | $17.00 | +38% | Aug 6 | SEC |
| Aug 7 | Green Jeremy +210% Owner | $10.20M | 600,000 | $17.00 | +103% | Aug 6 | SEC |
| Aug 6 | Fhmls Xi, L.P. +210% Owner | $10M | 588,235 | $17.00 | +11% | Aug 6 | SEC |